Carvana
When Carvana shares dipped lower in after-hours trading following its earnings release, Wells Fargo analyst Zachary Fadem was taken aback, noting we are scratching our heads. The online used car retailer, which has fallen 24% in the last three months, reported better-than-expected retail unit growth and beat his GPU estimate by 6%. It also posted a 50% narrower EBITDA loss than previously expected.
As such, Fadem reiterated a Buy rating. In addition, he left the $340 price target as is, suggesting 50% upside potential.
Fadem commented, CVNA continues to fire on all cylinders as average weekly units stepped up by +1,600/week (vs. +600-700 in Q3/Q4) suggesting throughput bottlenecks are alleviating, demand remains elevated and underlying business productivity is also tracking better-than-expected.
Operator
Good morning, and thank you for joining us today for the Select Medical Holdings Corporation earnings conference call to discuss the first-quarter 2021 results and the company s business outlook. Speaking today are the company s executive chairman and co-founder, Robert Ortenzio; and the company s executive vice president and chief financial officer, Martin Jackson. Management will give you an overview of the quarter and open the call for questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to the Select plans, expectations, strategies, intentions and beliefs.
Earnings Scheduled For May 6, 2021 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Quarterly Results
Earnings per share were up 121.62% over the past year to $0.82, which beat the estimate of $0.61.
Revenue of $1,547,000,000 rose by 9.33% from the same period last year, which beat the estimate of $1,440,000,000.
Outlook
Price Action
52-week low: $12.83
Company Profile
Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centers are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 100 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,700 rehabilitation clinics. The Concentra segment includes over 500 institutions. The company is headquartered in Pennsylvani
Operator
Good morning, and thank you for joining us today for Select Medical Holdings Corporation s earnings conference call to discuss the fourth-quarter and full-year 2020 results and the company s business outlook. Speaking today are the company s executive chairman and co-founder, Robert Ortenzio; and the company s executive vice president and chief financial officer, Martin Jackson. Management will give you an overview of the quarter and then open the call for your questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or future financial performance of the company, including, without limitation, statements regarding operating results, growth opportunities and other statements that refer to Select Medical plans, expectations, strategies, intentions and beliefs.